Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Julia E. Hood, Caleb J. Banta-Green, Jeffrey S. Duchin, Joseph Breuner, Wendy Dell, Brad Finegood, Sara N. Glick, Malin Hamblin, Shayla Holcomb, Darla Mosse, Thea Oliphant-Wells & Mi-Hyun Mia Shim. (2020) Engaging an unstably housed population with low-barrier buprenorphine treatment at a syringe services program: Lessons learned from Seattle, Washington. Substance Abuse 41:3, pages 356-364.
Read now
Read now
Marcus A. Bachhuber$suffix/text()$suffix/text(), Cole Thompson$suffix/text()$suffix/text(), Ann Prybylowski$suffix/text()$suffix/text(), José Benitez$suffix/text()$suffix/text(), Silvana Mazzella$suffix/text()$suffix/text() & David Barclay$suffix/text()$suffix/text(). (2018) Description and outcomes of a buprenorphine maintenance treatment program integrated within Prevention Point Philadelphia, an urban syringe exchange program. Substance Abuse 39:2, pages 167-172.
Read now
Read now
Xiaofan Li, Daryl Shorter & Thomas R Kosten. (2014) Buprenorphine in the treatment of opioid addiction: opportunities, challenges and strategies. Expert Opinion on Pharmacotherapy 15:15, pages 2263-2275.
Read now
Read now
Howard Padwa, Darren Urada, Valerie
P. Antonini, Allison Ober, Desirée
A. Crèvecoeur-MacPhail & Richard
A. Rawson. (2012) Integrating Substance Use Disorder Services with Primary Care: The Experience in California. Journal of Psychoactive Drugs 44:4, pages 299-306.
Read now
Read now
Sharon Stancliff, Herman Joseph, Chunki Fong, Terry Furst, SandraD. Comer & Perrine Roux. (2012) Opioid Maintenance Treatment as a Harm Reduction Tool for Opioid-Dependent Individuals in New York City: The Need to Expand Access to Buprenorphine/Naloxone in Marginalized Populations. Journal of Addictive Diseases 31:3, pages 278-287.
Read now
Read now
Articles from other publishers (16)
Omeid Heidari, Kayla Tormohlen, Derek T. DangerfieldIIII, Karin E. Tobin, Jason E Farley & Shoshana V. Aronowitz. (2022) Barriers and facilitators to primary care engagement for people who inject drugs: A systematic review. Journal of Nursing Scholarship 55:3, pages 605-622.
Crossref
Crossref
Marina Gaeta Gazzola, Iain D. Carmichael, Nicholaus J. Christian, Xiaoying Zheng, Lynn M. Madden & Declan T. Barry. (2023) A National Study of Homelessness, Social Determinants of Health, and Treatment Engagement Among Outpatient Medication for Opioid Use Disorder-Seeking Individuals in the United States. Substance Abuse 44:1-2, pages 62-72.
Crossref
Crossref
Kristi Hill, Laura Nussdorf, Julia D. Mount, Rachel Silk, Chloe Gross, David Sternberg, Phyllis Bijole, Miriam Jones, Randy Kier, Dana Mccullough, Poonam Mathur, Shyam Kottilil, Henry Masur, Sarah Kattakuzhy & Elana S. Rosenthal. (2022) Initiation of Low-threshold Buprenorphine in Nontreatment Seeking Patients With Opioid Use Disorder Engaged in Hepatitis C Treatment. Journal of Addiction Medicine 16:1, pages 10-17.
Crossref
Crossref
Matthew F. McLaughlin, Rick Li, Nicolás Domínguez Carrero, Paul A. Bain & Avik Chatterjee. (2021) Opioid use disorder treatment for people experiencing homelessness: A scoping review. Drug and Alcohol Dependence 224, pages 108717.
Crossref
Crossref
Danielle R. Fine, Elizabeth Lewis, Karen Weinstock, Joseph Wright, Jessie M. Gaeta & Travis P. Baggett. (2021) Office-Based Addiction Treatment Retention and Mortality Among People Experiencing Homelessness. JAMA Network Open 4:3, pages e210477.
Crossref
Crossref
Shelly R. Noe & Teresa Keller. (2020) Office-Based Buprenorphine Treatment. Journal of Addictions Nursing 31:1, pages 23-29.
Crossref
Crossref
Jamie Carter, Barry Zevin & Paula J. Lum. (2019) Low barrier buprenorphine treatment for persons experiencing homelessness and injecting heroin in San Francisco. Addiction Science & Clinical Practice 14:1.
Crossref
Crossref
Matthew Tierney, Katerina Melino, Adebowale Adeniji, Martha Shumway, Isabel E. Allen & Catherine M. Waters. (2018) Two Different Buprenorphine Treatment Settings With Similar Retention Rates: Implications for Expanding Access to Treatment for Opioid Use Disorder. Journal of the American Psychiatric Nurses Association 25:4, pages 305-313.
Crossref
Crossref
Devesh Vashishtha, Maria Luisa Mittal & Daniel Werb. (2017) The North American opioid epidemic: current challenges and a call for treatment as prevention. Harm Reduction Journal 14:1.
Crossref
Crossref
Pooja Lagisetty, Katarzyna Klasa, Christopher Bush, Michele Heisler, Vineet Chopra & Amy Bohnert. (2017) Primary care models for treating opioid use disorders: What actually works? A systematic review. PLOS ONE 12:10, pages e0186315.
Crossref
Crossref
Helena Hansen, Carole Siegel, Joseph Wanderling & Danae DiRocco. (2016) Buprenorphine and methadone treatment for opioid dependence by income, ethnicity and race of neighborhoods in New York City. Drug and Alcohol Dependence 164, pages 14-21.
Crossref
Crossref
Reisel Berger, Carmen Pulido, Jonathan Lacro, Stephen Groban & Shannon Robinson. (2014) Group Medication Management for Buprenorphine/Naloxone in Opioid-Dependent Veterans. Journal of Addiction Medicine 8:6, pages 415-420.
Crossref
Crossref
Michelle R. Lofwall, Judith Martin, Matt Tierney, Mélina Fatséas, Marc Auriacombe & Nicholas Lintzeris. (2014) Buprenorphine Diversion and Misuse in Outpatient Practice. Journal of Addiction Medicine 8:5, pages 327-332.
Crossref
Crossref
Lyn Stankiewicz Murphy, Marla T. Oros & Susan G. Dorsey. (2014) The Baltimore Buprenorphine Initiative. Journal of Addictions Nursing 25:1, pages 16-25.
Crossref
Crossref
Rebecca T. BrownMichael A. Steinman. (2013) Characteristics of Emergency Department Visits by Older Versus Younger Homeless Adults in the United States. American Journal of Public Health 103:6, pages 1046-1051.
Crossref
Crossref
. (2012) Current World Literature. Current Opinion in Psychiatry 25:3, pages 251-259.
Crossref
Crossref